Research graph
References from Building Effective Multimodal Care for Obesity and Comorbidities in the GLP-1 Therapy Era. Local targets link to admitted publications; unresolved targets remain external evidence.
Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults.
10.1016/s0140-6736(23)02750-2 · 2024 · External reference
Obesity rise plateaus in developed nations and accelerates in developing nations.
10.1038/s41586-026-10383-0 · 2026 · External reference
World Health Organization Guideline on the use and indications of glucagon-like peptide-1 therapies for the treatment of obesity in adults.
10.1001/jama.2025.24288 · 2026 · External reference
Combined associations of GLP-1 receptor agonists and a healthy lifestyle with cardiovascular outcomes among individuals with type 2 diabetes.
10.1016/s2213-8587(25)00395-x · 2026 · External reference
Lifestyle modification and incretin-based therapy for obesity.
10.1001/jama.2026.4106 · 2026 · External reference
From endorsement of the WHO Acceleration Plan to Stop Obesity to national implementation: country progress on health system preparedness to scale up a comprehensive obesity chronic care programme.
10.1016/s2214-109x(25)00496-6 · 2026 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
